Sign in
4

Changes in Ownership

Adicet Bio, Inc. Filed Acc 0001209191-23-046096

Options or other derivatives

  • Director acquired 100,400 shares (grant or award)
  • Director returned 100,400 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Sinclair Andrew Director 2023-08-14 Returned to the company · Stock Option (Right to Buy) −28,828 0 D
Sinclair Andrew Director 2023-08-14 Grant or award · Stock Option (Right to Buy) +28,828 28,828 D
Sinclair Andrew Director 2023-08-14 Returned to the company · Stock Option (Right to Buy) −18,500 0 D
Sinclair Andrew Director 2023-08-14 Grant or award · Stock Option (Right to Buy) +18,500 18,500 D
Sinclair Andrew Director 2023-08-14 Returned to the company · Stock Option (Right to Buy) −8,172 0 D
Sinclair Andrew Director 2023-08-14 Grant or award · Stock Option (Right to Buy) +8,172 8,172 D
Sinclair Andrew Director 2023-08-14 Returned to the company · Stock Option (Right to Buy) −18,500 0 D
Sinclair Andrew Director 2023-08-14 Grant or award · Stock Option (Right to Buy) +18,500 18,500 D
Sinclair Andrew Director 2023-08-14 Returned to the company · Stock Option (Right to Buy) −26,400 0 D
Sinclair Andrew Director 2023-08-14 Grant or award · Stock Option (Right to Buy) +26,400 26,400 D
Loading xslF345X05/doc4.xml…